Biocon Limited (BIOCON) Share Analysis
NSE · Healthcare · Pharmaceuticals
Biocon Limited (NSE: BIOCON) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 200, NIFTY 500, NIFTY Healthcare Index. As of 21 Sep 2026, the share price was ₹385.00, market capitalisation ₹62,743 Cr, P/E 86.3, ROE 1.4%.
Get the AI verdict on BIOCON: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
BIOCON price and valuation
- Share price
- ₹385.00
- Market cap
- ₹62,743 Cr
- P/E ratio
- 86.3
- P/B ratio
- 1.83
- EPS
- ₹3.36
- Book value per share
- ₹210.00
- Dividend yield
- 0.13%
BIOCON profitability and growth
- ROE
- 1.4%
- ROCE
- 3.61%
- Debt to equity
- 0.42
- Revenue growth (3 yr)
- 15%
- Revenue growth (5 yr)
- 19%
- Profit growth (3 yr)
- -15%
- Profit growth (5 yr)
- -12%
BIOCON 52-week range
- 52-week high
- ₹447.15
- 52-week low
- ₹337.05
- Face value
- ₹5.00
BIOCON shareholding pattern
- Promoters
- 44.68%
- FIIs
- 8.14%
- DIIs
- 23.33%
- Public
- 23.75%
Index membership: NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 100, NIFTY Midcap 150, NIFTY MidSmallcap 400, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.